Cell Harvesting

Global Cell Harvesting Market to Reach US$516.3 Million by 2030

The global market for Cell Harvesting estimated at US$333.5 Million in the year 2024, is expected to reach US$516.3 Million by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Peripheral Blood, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$271.0 Million by the end of the analysis period. Growth in the Bone Marrow segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$96.7 Million While China is Forecast to Grow at 10.3% CAGR

The Cell Harvesting market in the U.S. is estimated at US$96.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$47.7 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Cell Harvesting Market - Key Trends & Drivers Summarized

What is Cell Harvesting and Why is it Pivotal in Biomedical Research?

Cell harvesting is a crucial process in the field of biotechnology and medical research, involving the collection of cells from culture media during the logarithmic growth phase to maximize their viability for downstream applications. This technique is foundational for various biomedical pursuits, including therapeutic treatments, regenerative medicine, and research on cellular behaviors and genetics. The cells harvested are used to develop vaccines, model diseases, perform drug screening, and even cultivate tissues and synthetic organs. Effective cell harvesting is critical because the quality of the cells collected directly influences the reliability and effectiveness of experimental outcomes and clinical interventions. As such, advancements in cell harvesting methods continue to focus on enhancing the efficiency and purity of the cells collected, which is essential for the progress of medical science and treatment.

How Technological Advancements Are Transforming Cell Harvesting

The evolution of cell harvesting technologies has significantly improved the efficiency and safety of these procedures. Innovations include automated systems that reduce the risk of contamination and human error, enhancing the reproducibility of results in research and clinical environments. Such systems use sophisticated sensors and algorithms to optimize the timing and techniques of cell collection, ensuring that cells are harvested at their peak viability. Additionally, the integration of microfluidic devices has revolutionized cell harvesting by enabling the handling of smaller volume samples with higher precision, minimizing cell damage and loss. These technological advancements not only streamline workflows but also open new avenues for research and therapies that require highly specific and viable cells, thereby pushing the boundaries of what`s possible in medical treatments and biotechnological applications.

Emerging Trends in the Cell Harvesting Market

Several emerging trends are shaping the future of the cell harvesting market, driven by the expanding scope of biotechnological applications and the growing demand for personalized medicine. There is an increasing investment in stem cell research, where efficient cell harvesting is essential for cultivating stem cells used in regenerative treatments and disease modeling. The push towards personalized medicine is also driving the need for more sophisticated cell harvesting techniques that can provide tailored cellular materials for individual patients` treatments. Moreover, the biopharmaceutical industry`s growth fuels demand for cells used in drug development and testing, necessitating large-scale cell harvesting solutions that maintain cell integrity and functionality. As the market for cell-based products grows, regulatory standards are becoming more stringent to ensure that cell harvesting processes are safe, effective, and consistent, which influences market practices and technologies.

What Drives the Growth of the Cell Harvesting Market?

The growth in the cell harvesting market is driven by several factors, including the increasing prevalence of chronic diseases, the rising demand for biopharmaceuticals, advancements in cell-based research, and the growing focus on personalized medicine. The aging global population and the corresponding rise in healthcare needs are accelerating the demand for innovative treatments and therapies, many of which rely on harvested cells. Technological innovations that enhance the efficiency and yield of cell harvesting are also critical, as they improve the feasibility and cost-effectiveness of cell-based approaches. Additionally, the expanding regenerative medicine field, which utilizes harvested cells to engineer tissues and organs, is a significant market driver. Consumer behavior, particularly the increasing preference for targeted and effective treatments with fewer side effects, supports the adoption of therapies involving harvested cells. Moreover, government and private funding for research in cell dynamics and genetic engineering are contributing to the market`s expansion, reflecting a robust interest in advancing healthcare solutions through improved cell harvesting technologies.

SCOPE OF STUDY:

The report analyzes the Cell Harvesting market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Manual, Automated); Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, Other Applications); End-Use (Biotech & Biopharma Companies, Research Institutes, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 30 Featured) -

• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• Corning, Inc.
• Sartorius AG
• Arthrex, Inc.
• SP Industries, Inc.
• Trevigen, Inc.
• ANGLE PLC
• Ranfac Corporation
• ADS Biotec, Inc.
• Biotium, Inc.
• Global Life Sciences Solutions USA LLC (Cytiva)

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.